(Q39477975)

12 September 2017

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting (English)

1 reference

12 September 2017

0 references

1 reference

A V Taira

1

1 reference

12 September 2017

G S Merrick

2

1 reference

12 September 2017

R W Galbreath

3

1 reference

12 September 2017

H Andreini

4

1 reference

12 September 2017

W Taubenslag

5

1 reference

12 September 2017

R Curtis

6

1 reference

12 September 2017

W M Butler

7

1 reference

12 September 2017

E Adamovich

8

1 reference

12 September 2017

K E Wallner

9

1 reference

12 September 2017

29 September 2009

1 reference

Prostate Cancer and Prostatic Diseases

12 September 2017

1 reference

12 September 2017

13

1 reference

12 September 2017

1

1 reference

12 September 2017

71-77

1 reference

Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Saturation biopsy for detecting and characterizing prostate cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

How good is MRI at detecting and characterising cancer within the prostate?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Repeat prostate needle biopsy: who needs it?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Prostate cancer detection with office based saturation biopsy in a repeat biopsy population

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Saturation technique does not decrease cancer detection during followup after initial prostate biopsy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

The morbidity of transperineal template-guided prostate mapping biopsy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Saturation technique does not improve cancer detection as an initial prostate biopsy strategy

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Detailed mapping of prostate carcinoma foci: biopsy strategy implications

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Incidence and clinical significance of false-negative sextant prostate biopsies.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834351

Predictors of prostate cancer after initial negative systematic 12 core biopsy

21 August 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.42

Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.42

Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.42

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.42

Stereotactic transperineal prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.42

Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.42

Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19786982

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/PCAN.2009.42

1 reference

12 September 2017

1 reference

12 September 2017

PubMed publication ID

19786982

1 reference